Cell delivery therapeutics for musculoskeletal regeneration
- PMID: 20398712
- DOI: 10.1016/j.addr.2010.04.004
Cell delivery therapeutics for musculoskeletal regeneration
Abstract
The last decade has witnessed the development of cell-based therapy as a major biomedical research area, including the treatment of musculoskeletal diseases. Both differentiated and undifferentiated stem cells have been used as starting cell sources. In particular, the use of multipotent adult mesenchymal stem cells holds great promise for future therapeutic strategies. In addition to the cell type used, the cell delivery system is also of critical importance in cell-based therapy. Cell delivery may be achieved by direct cell injection or by grafting engineered constructs derived by cell seeding into natural or synthetic biomaterial scaffolds. While direct injection is the most direct and convenient means of cell delivery, the latter approach is capable of producing three-dimensional engineered tissues with mechanical properties compatible with those of various musculoskeletal tissues. This review will focus on the functional approach of using biomaterial scaffold materials as cell carriers for musculoskeletal applications, as well as the use of cell-based gene therapy for tissue engineering and regeneration.
2010 Elsevier B.V. All rights reserved.
Similar articles
-
Stem cells as vehicles for orthopedic gene therapy.Gene Ther. 2004 Feb;11(4):417-26. doi: 10.1038/sj.gt.3302197. Gene Ther. 2004. PMID: 14724684 Review.
-
Current strategies for cell delivery in cartilage and bone regeneration.Curr Opin Biotechnol. 2004 Oct;15(5):411-8. doi: 10.1016/j.copbio.2004.08.010. Curr Opin Biotechnol. 2004. PMID: 15464370 Review.
-
Therapeutic potential of chitosan and its derivatives in regenerative medicine.J Surg Res. 2006 Jun 15;133(2):185-92. doi: 10.1016/j.jss.2005.12.013. Epub 2006 Feb 3. J Surg Res. 2006. PMID: 16458923 Review.
-
Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy.J Cell Biochem. 2009 Oct 15;108(3):537-46. doi: 10.1002/jcb.22296. J Cell Biochem. 2009. PMID: 19681040 Review.
-
Clinical applications of musculoskeletal tissue engineering.Br Med Bull. 2008;86:7-22. doi: 10.1093/bmb/ldn016. Epub 2008 Apr 17. Br Med Bull. 2008. PMID: 18424445 Review.
Cited by
-
Current status of bone graft options for anterior interbody fusion of the cervical and lumbar spine.Neurosurg Rev. 2014 Jan;37(1):23-37. doi: 10.1007/s10143-013-0483-9. Epub 2013 Jun 7. Neurosurg Rev. 2014. PMID: 23743981 Review.
-
Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential.Stem Cell Res Ther. 2014 Feb 21;5(1):25. doi: 10.1186/scrt414. Stem Cell Res Ther. 2014. PMID: 24559797 Free PMC article.
-
[New experimental strategies in cartilage surgery].Orthopade. 2017 Nov;46(11):947-953. doi: 10.1007/s00132-017-3479-2. Orthopade. 2017. PMID: 28993845 Review. German.
-
Stem cells in tooth tissue regeneration--challenges and limitations.Stem Cell Rev Rep. 2011 Sep;7(3):683-92. doi: 10.1007/s12015-011-9237-7. Stem Cell Rev Rep. 2011. PMID: 21331452 Review.
-
Role of Mesenchymal Stem Cells Densities When Injected as Suspension in Joints with Osteochondral Defects.Cartilage. 2019 Jan;10(1):61-69. doi: 10.1177/1947603517708333. Epub 2017 May 10. Cartilage. 2019. PMID: 28486813 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources